Research says over one-third of pre-approved Rx drugs have not completed the FDA approval process
CATONSVILLE, Md. – The Food and Drug Administration’s (FDA) Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market.